288 related articles for article (PubMed ID: 8093570)
1. Thirty years of dopamine research.
Carlsson A
Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
[No Abstract] [Full Text] [Related]
2. Nigral and adrenal grafts in parkinsonism: recent basic and clinical studies.
Olson L; Backlund EO; Gerhardt G; Hoffer B; Lindvall O; Rose G; Seiger A; Strömberg I
Adv Neurol; 1987; 45():85-94. PubMed ID: 3030073
[No Abstract] [Full Text] [Related]
3. Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans.
Kopin IJ; Bankiewicz KS; Plunkett RJ; Jacobowitz DM; Oldfield EH
Adv Neurol; 1993; 60():707-14. PubMed ID: 8420215
[No Abstract] [Full Text] [Related]
4. The visual system in Parkinson's disease.
Bodis-Wollner I; Tagliati M
Adv Neurol; 1993; 60():390-4. PubMed ID: 8420159
[No Abstract] [Full Text] [Related]
5. [Neurobiologic and pharmacologic studies on the pathogenesis of Parkinson disease].
Brücke T; Riederer P
Wien Med Wochenschr; 1986 Aug; 136(15-16):401-8. PubMed ID: 2878540
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of parkinsonian motor abnormalities.
Wichmann T; DeLong MR
Adv Neurol; 1993; 60():53-61. PubMed ID: 8420185
[No Abstract] [Full Text] [Related]
7. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
Cole DG
Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
[No Abstract] [Full Text] [Related]
8. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
9. MPTP and other Parkinson-inducing agents.
Schapira AH
Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):396-400. PubMed ID: 1623269
[TBL] [Abstract][Full Text] [Related]
10. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
Graybiel AM; Moratalla R; Quinn B; DeLanney LE; Irwin I; Langston JW
Adv Neurol; 1993; 60():34-9. PubMed ID: 8420148
[No Abstract] [Full Text] [Related]
11. Pathogenesis of Parkinson's disease.
Riederer P; Lange KW
Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):295-300. PubMed ID: 1623255
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and basal ganglia.
Hikosaka O
Jpn J Psychiatry Neurol; 1991 Jun; 45(2):511. PubMed ID: 1762258
[No Abstract] [Full Text] [Related]
13. Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Kito S; Miyoshi R; Mizuno K; Nitta K; Matsubayashi H; Yamamura Y; Tahara E
Adv Neurol; 1987; 45():159-65. PubMed ID: 2881441
[No Abstract] [Full Text] [Related]
14. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
Di Chiara G; Morelli M
Adv Neurol; 1993; 60():102-6. PubMed ID: 8093571
[No Abstract] [Full Text] [Related]
15. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism.
Chiueh CC; Miyake H; Peng MT
Adv Neurol; 1993; 60():251-8. PubMed ID: 8380519
[No Abstract] [Full Text] [Related]
16. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives.
Guridi J; Obeso JA
Adv Neurol; 1997; 74():235-47. PubMed ID: 9348418
[No Abstract] [Full Text] [Related]
17. Three types of akinesia in the progressive course of Parkinson's disease.
Narabayashi H
Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577
[No Abstract] [Full Text] [Related]
18. Heterogeneity of dopamine receptors.
Jarvie KR; Caron MG
Adv Neurol; 1993; 60():325-33. PubMed ID: 8380525
[No Abstract] [Full Text] [Related]
19. Glutamate and Parkinson's disease.
Greenberg DA
Ann Neurol; 1994 Jun; 35(6):639. PubMed ID: 7911652
[No Abstract] [Full Text] [Related]
20. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
Mash DC; Sanchez-Ramos J; Weiner WJ
Adv Neurol; 1993; 60():133-9. PubMed ID: 8420130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
